GlassScriptPhysician profile
Denise Whittam
NPI 1699742403
$342,724.59
in general payments reported to CMS, 2019-2025
11 companies · $116K in 2025
The $116K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,691 · 2020: $14K · 2021: $18K · 2022: $65K · 2023: $50K · 2024: $73K · 2025: $116K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $190K · Travel and Lodging: $32K · Food and Beverage: $9,843 · Consulting Fee: $7,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $190,200.00 |
| Travel and Lodging | $32,100.76 |
| Food and Beverage | $9,843.37 |
| Consulting Fee | $7,475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $339,072.09 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,725.37 | 2021-2025 | Precision 1, Precision7, Total30 |
| Bausch & Lomb Americas INC. | $801.61 | 2022-2025 | Miebo, Xiidra, Infuse |
| Regeneron Healthcare Solutions, INC. | $242.28 | 2021-2022 | |
| Glaukos Corporation | $230.13 | 2022 | |
| Integra Lifesciences Corporation | $200.95 | 2022-2023 | Medihoney, Biodrestore, Biofix |
| Abbvie INC. | $166.20 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $122.43 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $96.00 | 2021 | |
| Coopervision INC. | $46.05 | 2024 | Misight Contact Lens |
| Allergan, INC. | $21.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Whittam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.